4//SEC Filing
Singh Gurdev Dave 4
Accession 0001493152-21-019251
CIK 0001716166other
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 9:44 PM ET
Size
6.4 KB
Accession
0001493152-21-019251
Insider Transaction Report
Form 4
Singh Gurdev Dave
DirectorChief Medical Officer10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2021-08-05$2.72/sh+30,000$81,600→ 46,667 totalExercise: $2.72Exp: 2026-08-05→ Common Stock (46,667 underlying)
Holdings
- 3,219,705(indirect: See footnote)
Common Stock
Footnotes (2)
- [F1]Shares held by Himmat LP, of which reporting person is a member and manager.
- [F2]30,000 stock options granted on August 5, 2021. One-half vested immediately and one-eighth vests quarterly every three months through August 5, 2022.
Documents
Issuer
Vivos Therapeutics, Inc.
CIK 0001716166
Entity typeother
Related Parties
1- filerCIK 0001835538
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 9:44 PM ET
- Size
- 6.4 KB